Trial · NCT06027593
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| 28-day Community Acquired Pneumonia-related Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Children | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 13 | Participants | ||
| 28-day Community Acquired Pneumonia-related Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Children | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 20 | Participants | ||
| 28-day Readmissions for Pediatric Community Acquired Pneumonia | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 8 | Participants | ||
| 28-day Readmissions for Pediatric Community Acquired Pneumonia | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 14 | Participants | ||
| Guideline-concordant Decision to Prescribe Antibiotics for Adult Pharyngitis | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 1464 | Participants | ||
| Guideline-concordant Decision to Prescribe Antibiotics for Adult Pharyngitis | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 2492 | Participants | ||
| Guideline-concordant Antibiotic Choice Adult Pharyngitis | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 27 | Participants | ||
| Guideline-concordant Antibiotic Choice Adult Pharyngitis | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 160 | Participants | ||
| Guideline-concordant Antibiotic Duration for Adult Pharyngitis | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 31 | Participants | ||
| Guideline-concordant Antibiotic Duration for Adult Pharyngitis | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 175 | Participants | ||
| 30-day Pharyngitis Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Adults | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 291 | Participants | ||
| 30-day Pharyngitis Outpatient Revisits (Emergency Department, Urgent Care, or Primary Care) in Adults | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 578 | Participants | ||
| 30-day Deep Neck Space Infection Admission | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 0 | Participants | ||
| 30-day Deep Neck Space Infection Admission | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 1 | Participants | ||
| Guideline-concordant Decision to Prescribe Antibiotics for Pediatric Acute Otitis Media | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 9935 | Participants | ||
| Guideline-concordant Decision to Prescribe Antibiotics for Pediatric Acute Otitis Media | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 8547 | Participants | ||
| Guideline-concordant Antibiotic Choice for Pediatric Acute Otitis Media | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 7498 | Participants | ||
| Guideline-concordant Antibiotic Choice for Pediatric Acute Otitis Media | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 6828 | Participants | ||
| Guideline-concordant Antibiotic Duration for Pediatric Acute Otitis Media | Pre-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 7565 | Participants | ||
| Guideline-concordant Antibiotic Duration for Pediatric Acute Otitis Media | Post-Intervention: Patients Diagnosed With Conditions of Interest During Study Period | 7281 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06027593/results?page=2